LETTER TO THE EDITOR REGARDING “ARTIFICIAL WOMB TECHNOLOGIES-INNOVATION AT THE EDGE OF VIABILITY: ETHICAL CONSIDERATIONS”

jpedsurg.org

Jennifer Paul et al. claim that artificial womb technology (or “AWT”) aims “to extend fetal development ex utero” by “replicating the intrauterine environment” outside of the maternal body.[1] The legal and moral status of subjects within AWs has been debated, though Paul et al.’s presentation of these issues is inaccurate. They claim, for example, that subjects within AWs “occupy a legal gray zone, with unclear entitlement to care, protection, or representation.”[1] Under United States law, this is false.

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Nov 2025 · 1 min read

In brief

This letter critiques claims about the legal status of subjects in artificial womb technology, specifically challenging assertions that such subjects occupy a legal gray zone under U.S. law. The author addresses ethical and legal considerations surrounding ex utero fetal development and artificial womb technologies in neonatal care.

- Artificial womb technology (AWT) aims to replicate intrauterine environment for ex utero fetal development. - Legal status of subjects in artificial wombs is NOT a gray zone under current U.S. law, contrary to some claims. - Accurate understanding of existing legal frameworks is essential when discussing AWT ethical implications. - Misrepresentation of legal protections for AW subjects can mislead clinical and policy discussions. - Clinicians should verify legal claims about emerging technologies rather than accepting assertions at face value.

Written by the GCMD Library team from the article.

Read it at the source ↗